This BSE small-cap healthcare company has tripled its investors' wealth in two years!

Today, the stock opened at Rs 76.65 and touched a high and low of Rs 80.85 and Rs 76.65.

Today, the stock opened at Rs 76.65 and touched a high and low of Rs 80.85 and Rs 76.65. It has a 52-week high and low of Rs 82.75 and Rs 33.80, respectively on BSE.  

On December 8, shares of Artemis Medicare Services closed at Rs 79.10, representing a gain of more than 300 per cent over the previous two years. The company, which was trading at Rs 19.47 on December 4, 2020, generated multibagger returns during a two-year holding period, more than tripling the wealth of its investors. Artemis Medical Services stocks have delivered a return of 115 per cent in a year. While in the last 6 months, the stock has increased by nearly 72 per cent. As of December 4, 2020, the S&P BSE 500 index, on the other hand, has seen gains of 38.80 per cent during the previous two years. 

In its recent quarter of Q2FY23, the company's operating revenue increased on a consolidated basis by 34.8 per cent YoY to Rs 1874.60 crore from Rs 1390.40 crore. The profit after tax (PAT) increased from Rs 81 crore in the same quarter last year by Rs 8.3 per cent YoY to Rs 87.70 crore this year. The TTM PE for the company is currently 27.01x. With a market capitalization of Rs 1057.92 crore, Artemis Medicare Services achieved ROE & ROCE of 9.65 per cent and 9.98 per cent, respectively. 

Artemis Medicare Services Ltd (AMSL) is a healthcare company founded in 2004 by the Apollo Tyres Group's promoters. The company operates a 318-bed multi-speciality tertiary care hospital in Gurgaon. It specialises in Orthopedics and Joint Replacement, Oncology, Cardiovascular, Neurosciences, and Bariatric and Minimally Invasive Surgery. AMSL has received NABH accreditation. The chain of asset-light centres is helping the company expand its footprint in tier 1 and 2 cities.